Summary of advantages and disadvantages of
existing and developing techniques for assessment of radiation exposure levels
Existing techniques |
Advantages |
Disadvantages |
Dicentric assay
|
- Low background "noise"
- Well calibrated
- Well researched
- >40 years experience of deployment
- Tested in triage mode
|
- Limited application to internal contamination
- Saturates at very high doses
- Technically demanding
|
Micronucleus assay
|
- Well calibrated
- Technically easier and faster throughput than the dicentric assay
|
- Limited persistence of the signal
- Background precludes low dose discrimination
- Saturates at high doses
|
FISH method
|
- Well calibrated
- Persistent signal
|
- Expensive reagents
- Technically demanding
|
PCC method
(Premature Chromosome Condensation)
|
- Avoids differential cell losses in partial body exposure
- Results can be obtained quickly
- Can detect exposure to high doses
|
- Rarely used
- Requires further calibration
|
Developing methods
|
Advantages
|
Disadvantages
|
γH2AX analysis
|
- Potentially highly useful
- Can detect radiosensitive individuals
- Could provide insight into the quality of radiation
|
- Probably requires analysis 1-2 days post-irradiation
- Time consuming although applicable for automation
|
Analysis of stable biomarkers
|
- Could be used for analysis of long times post-irradiation
- Could provide insight into radiation quality
|
- Time consuming
- Limited capacity for automation
|
Candidate protein biological dosimeters
|
- Potentially suitable candidate proteins exist
|
- Probably requires analysis 1-2 days post-irradiation
|
Genomic profiling
|
- Potentially highly sensitive
- Potentially high throughput
|
- Requires considerable further development
- Currently expensive technology
|
Proteomic profiling
|
|
- Currently insufficiently sensitive, time consuming, and expensive
|
Source: adapted from
High dose radiation effects and tissue injury, Report of the Independent Advisory Group on Ionising Radiation, Table 4.4, page 41 (Public Health England [PHE], formerly Health Protection Agency [HPA], UK, March 2009) (PDF - 865 KB)